BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Jul 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-07-02

Reporting Person: ASELAGE STEVE (EVP, Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-02	Common Stock	M	95345	$17.54	Acquired	154375	Direct
2012-07-02	Common Stock	S	95345	$40.00	Disposed	59030	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-02	Stock Option (right to buy)	$17.54	M	95345	Disposed	2016-11-20	Common Stock (95345)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 25, 2011.

F2: Original option vests 6/48ths on May 20, 2007 and 1/48th on the 20th of every month thereafter.